More Insights on the Use of γ-Secretase Inhibitors in Cancer Treatment.

Abstract excerpt

The NOTCH1 gene encodes a transmembrane receptor protein with activating mutations observed in many T-cell acute lymphoblastic leukemias (T-ALLs) and lymphomas, as well as in other tumor types, which has led to interest in inhibiting NOTCH1 signaling as a therapeutic target in cancer. Several classes of Notch inhibitors have been developed, including monoclonal antibodies against NOTCH receptors or ligands,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Amyloid Precursor Protein Secretases
• Share to Cell Line, Tumor